Search
for
Sort by
Research 241–270 of 1000+
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Ritlecitinib: First Approval
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- “<i>Nomen Omen</i>: The Myth of God Janus”
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- JAK inhibitors and alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- New drugs under investigation for the treatment of alopecias
- Novedades terapéuticas en tricología
- Alopecia in general medicine
- New Treatments for Hair Loss
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient